Actos and Bladder Cancer: Studies Say There’s a Link
Actos and Bladder Cancer Correlation
If you’ve been taking Actos for over a year, you may need to do two things: see a doctor and see an Actos lawyer.
Actos, a drug prescribed to treat Type 2 diabetes, has been the subject of numerous studies since the drug’s first release into the market in 1999. Prior to its release, Actos was linked to serious conditions such as bladder cancer, heart disease, bone fractures and blindness. Countries such as France and Germany have recalled Actos, but the U.S. has not.
Findings from a study this past August by the Perelman School of Medicine at the University of Pennsylvania revealed that diabetes patients who take Actos for more than a year are 2-3 times more likely to develop Actos bladder cancer.
A July study in the Canadian Medical Association Journal also found a connection between Actos and bladder cancer. This study found that taking Actos increases the risk of bladder cancer by 22 percent — in addition to the 40 percent risk that exists for people who simply have diabetes.
At the end of this year, Takeda Pharmaceuticals, the maker and manufacturer of Actos, is expected to complete a 10-year Actos study requested by the FDA. While the FDA has not recalled Actos, many Actos lawsuits have been and continue to be filed. Currently, there are two mass tort lawsuits against Actos — one in Los Angeles and one in Louisiana — involving hundreds of plaintiffs.
If you’ve been taking Actos for over a year, see your doctor right away for a bladder cancer screening. Also consider talking to an Actos bladder cancer lawyer to learn about your rights. When you’re ready, give us a call. We’ll find you the perfect Actos bladder lawyer for your case, 24/7, 365 days a year: [link_obfuscate_telephone tel=”1-800-380-8080″]. Our Live Chat feature can also help you connect with one of our helpful bilingual representatives. They are ready to help you in English and Spanish.